Effect of anti-CD38 monoclonal antibodies on hepatitis C virus replication in chronically infected patients with multiple myeloma: a prospective series

Leuk Lymphoma. 2023 Apr;64(4):900-903. doi: 10.1080/10428194.2023.2183731. Epub 2023 Mar 8.
No abstract available

Publication types

  • Letter
  • Research Support, N.I.H., Extramural

MeSH terms

  • ADP-ribosyl Cyclase 1
  • Antibodies, Monoclonal / adverse effects
  • Antineoplastic Agents* / therapeutic use
  • Hepacivirus
  • Hepatitis C*
  • Humans
  • Multiple Myeloma* / drug therapy
  • Virus Replication

Substances

  • Antibodies, Monoclonal
  • Antineoplastic Agents
  • ADP-ribosyl Cyclase 1